The Genesis RMN cardiac electrophysiological robot magnetic navigation system, represented in China by Shanghai Microport EP Medtech Co., Ltd, (SHA: 688351) has been granted marketing approval by the National Medical Products Administration (NMPA) in China.
Global Recognition and Enhanced Features
Developed by Stereotaxis, the Genesis RMN system has already received approval from the US Food and Drug Administration (FDA) and the CE mark in Europe. Building on the success of the original RMN system, the new product boasts an innovative structural design that delivers improvements in speed, reduced volume, weight, and enhanced operational flexibility.
Enhanced Performance and Surgical Efficiency
A key feature of the Genesis RMN system is a smaller magnet that rotates along the center of mass of the product, resulting in a speed increase of approximately 70% to 80% compared to the previous generation. This advancement effectively enhances surgical efficiency, making the system a significant advancement in the field of cardiac electrophysiology.-Fineline Info & Tech
